FivePrime is disÂcovÂerÂing and develÂopÂing novel therÂaÂpeuÂtic proÂteins and antiÂbodÂies by sysÂtemÂatÂiÂcally screenÂing all relÂeÂvant proÂteins in the human body to find the best proÂtein for treatÂment of a given clinÂiÂcal indiÂcaÂtion. FivePrimeâ??s ProÂScreen Engine enables the rapid proÂducÂtion and screenÂing of all therÂaÂpeuÂtiÂcally relÂeÂvant proÂteins in medically-â??â??focused assays at the highÂest qualÂity stanÂdards in the indusÂtry. This powÂerÂful approach is the polar oppoÂsite of the industryâ??s traÂdiÂtional â??one proÂtein at a timeâ??. The ProÂScreen Engine comÂprises the definÂiÂtive proÂtein colÂlecÂtion and screenÂing process for bioÂlogÂics disÂcovÂery and is unpreceÂdented in its effiÂciency, qualÂity, and scale. In addiÂtion to DBL Investors, investors include Domain AssoÂciates, VerÂsant VenÂtures, Kleiner Perkins CauÂfield and Byers, Texas Pacific Group, HealthÂCap, and Advanced TechÂnolÂogy Ventures.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Five Prime Therapeutics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Five Prime Therapeutics Inc market cap is $1.77B.
What is the 52-week high for Five Prime Therapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Five Prime Therapeutics Inc 52 week high is $38.90 as of September 07, 2025.
What is the 52-week low for Five Prime Therapeutics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Five Prime Therapeutics Inc 52 week low is $2.64 as of September 07, 2025.
What is Five Prime Therapeutics Inc stock price today?
Five Prime Therapeutics Inc stock price today is $38.00.
What was Five Prime Therapeutics Inc stock price yesterday?
Five Prime Therapeutics Inc stock price yesterday was $37.99.
What is the PE ratio of Five Prime Therapeutics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Five Prime Therapeutics Inc’s P/E ratio is -14.16.
What is the Price-to-Book ratio of Five Prime Therapeutics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Five Prime Therapeutics Inc P/B ratio is 14.2135.
What is the 50-day moving average of Five Prime Therapeutics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Five Prime Therapeutics Inc 50-day moving average is $31.66.